Development of a PTEN-siRNA activated scaffold to promote axonal regrowth following spinal cord injury

This study showcases the successful development of a <i>PTEN</i>-siRNA activated scaffold for SCI repair applications. Initially, siRNA was combined with the novel non-viral glycosaminoglycan-binding enhanced transduction (GET) peptide vector (image of GET vector from [22]). The formulated GET-siRNA nanoparticles effectively transfected primary neurons, a cell type generally considered challenging to transfect. Subsequently, siRNA-nanoparticles were incorporated into a hyaluronic acid scaffold enriched with neurotrophic extracellular matrix proteins (collagen IV and fibronectin) developed by our laboratory for spinal cord repair applications. Functionalisation of these scaffolds with <i>PTEN</i>-siRNA nanoparticles significantly enhanced their capacity to promote neurite outgrowth.Image 1.

Authors

Institutions

Publication Details

Journal
Bioactive Materials
Published
2026-02-09
DOI
https://doi.org/10.1016/j.bioactmat.2026.01.022
Primary Topic
Nerve injury and regeneration
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of a PTEN-siRNA activated scaffold to promote axonal regrowth following spinal cord injury

Cian O. O'Connor, Jack Maughan, Ian Woods, G Brunetti et al.
Bioactive Materials
Nerve injury and regeneration
article

Development of a PTEN-siRNA activated scaffold to promote axonal regrowth following spinal cord injury

Cian O. O'Connor, Jack Maughan, Ian Woods, G Brunetti, Martyna Stasiewicz, James E. Dixon, Adrian Dervan, Marko Dobricic, Tara K. McGuire, Fergal J. O'Brien
article en

Abstract

This study showcases the successful development of a <i>PTEN</i>-siRNA activated scaffold for SCI repair applications. Initially, siRNA was combined with the novel non-viral glycosaminoglycan-binding enhanced transduction (GET) peptide vector (image of GET vector from [22]). The formulated GET-siRNA nanoparticles effectively transfected primary neurons, a cell type generally considered challenging to transfect. Subsequently, siRNA-nanoparticles were incorporated into a hyaluronic acid scaffold enriched with neurotrophic extracellular matrix proteins (collagen IV and fibronectin) developed by our laboratory for spinal cord repair applications. Functionalisation of these scaffolds with <i>PTEN</i>-siRNA nanoparticles significantly enhanced their capacity to promote neurite outgrowth.Image 1.

Bioactive MaterialsVol. 60
University of Nottingham (GB), Royal College of Surgeons in Ireland (IE), Trinity College Dublin (IE), Advanced Materials and BioEngineering Research (IE), Nottingham Biomedical Research Centre (GB)
Openalex Percentile: Top 63%
Nerve injury and regeneration
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.